rs12153162

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018834.6(MATR3):​c.-43T>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.698 in 1,507,718 control chromosomes in the GnomAD database, including 369,403 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.57 ( 27398 hom., cov: 30)
Exomes 𝑓: 0.71 ( 342005 hom. )

Consequence

MATR3
NM_018834.6 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.64

Publications

13 publications found
Variant links:
Genes affected
MATR3 (HGNC:6912): (matrin 3) This gene encodes a nuclear matrix protein, which is proposed to stabilize certain messenger RNA species. Mutations of this gene are associated with distal myopathy 2, which often includes vocal cord and pharyngeal weakness. Alternatively spliced transcript variants, including read-through transcripts composed of the upstream small nucleolar RNA host gene 4 (non-protein coding) and matrin 3 gene sequence, have been identified. Pseudogenes of this gene are located on chromosomes 1 and X. [provided by RefSeq, Aug 2013]
MATR3 Gene-Disease associations (from GenCC):
  • amyotrophic lateral sclerosis type 21
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • distal myopathy with vocal cord weakness
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 5-139307373-T-A is Benign according to our data. Variant chr5-139307373-T-A is described in ClinVar as Benign. ClinVar VariationId is 263207.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.726 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MATR3NM_018834.6 linkc.-43T>A 5_prime_UTR_variant Exon 2 of 15 ENST00000394805.8 NP_061322.2 P43243-1Q9H4N1A0A0R4J2E8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MATR3ENST00000394805.8 linkc.-43T>A 5_prime_UTR_variant Exon 2 of 15 1 NM_018834.6 ENSP00000378284.3 P43243-1
MATR3ENST00000502929.5 linkc.-43T>A 5_prime_UTR_variant Exon 7 of 20 2 ENSP00000422319.1 A8MXP9

Frequencies

GnomAD3 genomes
AF:
0.568
AC:
85669
AN:
150886
Hom.:
27400
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.274
Gnomad AMI
AF:
0.578
Gnomad AMR
AF:
0.610
Gnomad ASJ
AF:
0.705
Gnomad EAS
AF:
0.247
Gnomad SAS
AF:
0.656
Gnomad FIN
AF:
0.660
Gnomad MID
AF:
0.647
Gnomad NFE
AF:
0.732
Gnomad OTH
AF:
0.597
GnomAD2 exomes
AF:
0.675
AC:
128217
AN:
189950
AF XY:
0.684
show subpopulations
Gnomad AFR exome
AF:
0.330
Gnomad AMR exome
AF:
0.703
Gnomad ASJ exome
AF:
0.726
Gnomad EAS exome
AF:
0.314
Gnomad FIN exome
AF:
0.684
Gnomad NFE exome
AF:
0.738
Gnomad OTH exome
AF:
0.699
GnomAD4 exome
AF:
0.713
AC:
966915
AN:
1356720
Hom.:
342005
Cov.:
40
AF XY:
0.714
AC XY:
481010
AN XY:
673782
show subpopulations
African (AFR)
AF:
0.298
AC:
7996
AN:
26822
American (AMR)
AF:
0.682
AC:
22041
AN:
32332
Ashkenazi Jewish (ASJ)
AF:
0.717
AC:
16520
AN:
23034
East Asian (EAS)
AF:
0.331
AC:
11002
AN:
33214
South Asian (SAS)
AF:
0.694
AC:
50450
AN:
72700
European-Finnish (FIN)
AF:
0.679
AC:
33223
AN:
48900
Middle Eastern (MID)
AF:
0.689
AC:
3512
AN:
5098
European-Non Finnish (NFE)
AF:
0.741
AC:
784704
AN:
1059112
Other (OTH)
AF:
0.675
AC:
37467
AN:
55508
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
13393
26786
40178
53571
66964
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19408
38816
58224
77632
97040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.567
AC:
85687
AN:
150998
Hom.:
27398
Cov.:
30
AF XY:
0.563
AC XY:
41482
AN XY:
73706
show subpopulations
African (AFR)
AF:
0.274
AC:
11243
AN:
41056
American (AMR)
AF:
0.609
AC:
9225
AN:
15140
Ashkenazi Jewish (ASJ)
AF:
0.705
AC:
2434
AN:
3454
East Asian (EAS)
AF:
0.247
AC:
1266
AN:
5124
South Asian (SAS)
AF:
0.656
AC:
3145
AN:
4792
European-Finnish (FIN)
AF:
0.660
AC:
6845
AN:
10378
Middle Eastern (MID)
AF:
0.647
AC:
189
AN:
292
European-Non Finnish (NFE)
AF:
0.732
AC:
49567
AN:
67760
Other (OTH)
AF:
0.596
AC:
1248
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1542
3085
4627
6170
7712
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
702
1404
2106
2808
3510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.510
Hom.:
1379
Bravo
AF:
0.548

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Amyotrophic lateral sclerosis type 21 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
Aug 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.073
DANN
Benign
0.64
PhyloP100
-1.6
Mutation Taster
=119/181
disease causing (long InDel)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12153162; hg19: chr5-138643062; COSMIC: COSV63075947; COSMIC: COSV63075947; API